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ORIGINAL ARTICLE
Percutaneous closure of the secundum type of
atrial septal defect (ASD) with Amplatzer septal
occluder (ASO) is an acceptable alternative to sur-
gical closure. Centrally located ASD is ideally
suited for percutaneous closure.1–5 However, mor-
phologic variations in ASDs are common whilst
the deficient superior-anterior (SA) rim is the most
frequently encountered variation.6–9 Recently, de-
spite there being a higher risk of disk impinge-
ment on the surrounding cardiac structures, or
left atrial disk of ASO prolapse in patients with
SA rim deficiency, application of ASO in such cases
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Background/Purpose: To evaluate the outcome of transcatheter closure of atrial septal defects (ASD) with
superior-anterior (SA) rim deficiency using Amplatzer septal occluder (ASO).
Methods: Between June 2003 and March 2007, 84 patients with secundum type ASD attempted trans-
catheter insertion of ASO in our institution. According to the transesophageal echocardiographic findings,
patients were divided into two groups: group A, with deficient SA rim (< 3 mm); group B, with sufficient
SA rim (≥ 3 mm). There were 43 children and 41 adults (age range, 2.0–79.4 years; mean age, 22.0 ± 20.2
years). The failure rate, complications and the presence of residual shunt were compared between the 
two groups.
Results: There were 34 patients in group A and 50 patients in group B. Failure of ASO implantation occurred
in six patients, three in each group. One patient had two ASOs implanted for two separate ASDs. Therefore,
the study cohort consisted of 78 patients with 79 ASO placed. Among 78 patients with successful implan-
tation, five (6.4%) had persistent small residual shunt during follow-up (range, 1–46 months; mean,
21.6 ± 12.0 months). There was no statistically significant difference between group A and group B in the
procedure’s failure rate (p = 0.682), complications (p = 1.0) and the presence of residual shunt (p = 0.381)
during the follow-up period.
Conclusion: ASD with deficient SA rim is a common variation. Similar to ASD with sufficient rims, trans-
catheter closure of secundum type ASD is also effective for ASD with SA rim deficiency. [J Formos Med Assoc
2007;106(12):986–991]
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has been described.7,8,10 The purpose of this study
was to evaluate the outcome of transcatheter clo-
sure of ASD with SA rim deficiency using ASO in
our institution.
Methods
Between June 2003 and March 2007, 87 patients
with secundum type ASD were referred to our in-
stitution for transcatheter insertion of ASO (AGA
Medical Corp., Golden Valley, MN, USA). The indi-
cation for closure was right ventricular volume
overload and/or the ratio of pulmonary blood
flow and systemic blood flow (Qp/Qs ratio) ≥ 1.5.
Three patients were excluded because the ASD
diameter was larger than 38 mm as demonstrated
on transesophageal echocardiography (TEE). Trans-
catheter closure of ASD using ASO was attempted
in 84 patients. There were 24 males and 60 fe-
males. Forty-three patients were children and 41
were adults. The mean age was 22.0 ± 20.2 years
(range, 2.0–79.4 years). Mean body weight was
41.1 ± 24.0 kg (range, 8.9–122.0 kg). Forty-seven
patients had symptoms, including exercise intol-
erance (n = 22), chest pain (n = 13), palpitation/
arrhythmia (n = 10), poor weight gain (n = 8),
stroke (n = 2) and syncope (n = 2).
The procedure was performed under general
anesthesia. All patients received prophylactic 
antibiotic treatment with one dose of cefazolin
(25 mg/kg) given intravenously. Intravenous hep-
arin (100 U/kg) was administered during the 
intervention. The morphologic characteristics of
the defect were evaluated by TEE before ASO clo-
sure. Echocardiographic study was performed
using the Philips SONOS 7500 system (Philips,
Andover, MA, USA). All patients had adequate
circumferential rims except the SA aspect. Patients
were divided into two groups according to the
TEE findings: group A (Figure 1), with SA rim de-
ficiency (< 3 mm); group B (Figure 2), with suffi-
cient SA rim (≥ 3 mm). In our first 35 cases, the
size of the ASD was measured by TEE and the
cylindrical Amplatzer sizing balloon (AGA Medical
Corp.). The size of the ASO was chosen based on
the latter with the device size equal to or exceed-
ing by 2–4 mm in diameter. After October 2004,
the size of the ASD was measured by TEE with-
out balloon sizing in most of our cases. The
measurement of ASD by TEE was modified accord-
ing to Carcagni and Presbitero’s study.11 All pa-
tients received aspirin (5 mg/kg/day) for 6 months
to prevent thromboembolic complications. Follow-
up echocardiographic studies were done on the
next day before discharge and at 3, 6 and 12
months after the procedure.
Statistical analysis
Results are expressed as mean ± standard deviation.
Comparison of parameters between the groups
was performed with unpaired Student’s t test,
A B
Figure 1. Transesophageal echocardiography shows atrial septal defect with deficient superior-anterior rim (arrow): 
(A) before and (B) after transcatheter Amplatzer septal occluder implantation. Ao = aorta; LA = left atrium; RA = right
atrium.
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Pearson’s χ2 test or Fisher’s exact test. Statistical
analyses were performed using SPSS version 9.0
(SPSS Inc., Chicago, IL, USA) for Windows. A value
of p less than 0.05 was considered to be statistically
significant.
Results
There were 34 patients in group A and 50 patients
in group B. The demographic and clinical data
are summarized in Table 1.
In our first 35 cases, the ASD diameter mea-
sured by TEE and balloon sizing was 17.9±7.2mm
and 20.3 ± 8.0 mm, respectively. The diameter
measured by balloon sizing was larger than that
measured by TEE. However, a discrepancy > 5 mm
was found in seven cases in our study. In these
cases, the ASO size was determined by the larger
one. In the other 49 cases, the diameter measured
by TEE only was 20.9 ± 7.2 mm.
The mean Qp/Qs ratio for all 84 patients 
was 2.5 ± 0.9 (range, 1.5–5.8), mean pulmonary
artery pressure was 19.0 ± 6.9 mmHg (range, 11–
55 mmHg), mean ASO size was 22.0 ± 8.2 mm
(range, 9–38 mm), and mean fluoroscopic time
was 11.4 ± 3.6 minutes (range, 4.7–21.3 minutes).
There were no statistically significant differences
between groups A and B with regard to age, sex,
body weight, Qp/Qs ratio, mean pulmonary artery
pressure, ASD diameter, and fluoroscopic time.
Seventy-nine ASO devices were successfully im-
planted in 78 patients, included one patient who
received two ASO implantations. ASO implanta-
tion failed in six patients, three in each group.
The procedure success rate was 92.9%.
Table 1. Clinical characteristics of patients with atrial septal defect
Group A: deficient SA rim Group B: sufficient SA rim
p
(n = 34) (n = 50)
Age (yr) 21.4 ± 22.3 22.5 ± 18.8 0.817
Sex (F/M) 28/6 32/18 0.068
Body weight (kg) 38.7 ± 26.9 42.7 ± 21.9 0.455
Qp/Qs ratio 2.3 ± 0.8 2.7 ± 1.0 0.092
Mean PAP (mmHg) 19.0 ± 5.7 19.1 ± 7.6 0.958
ASD diameter (mm) 18.4 ± 6.6 20.5 ± 7.7 0.189
Fluoroscopic time (min) 12.0 ± 3.5 10.9 ± 3.7 0.163
SA = superior-anterior; Qp/Qs = pulmonary blood flow/systemic blood flow; PAP = pulmonary artery pressure; ASD = atrial septal 
defect.
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Figure 2. Transesophageal echocardiography shows atrial septal defect with sufficient superior-anterior rim (arrow): 
(A) before and (B) after transcatheter Amplatzer septal occluder implantation. Ao = aorta; LA = left atrium; RA = right
atrium.
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During the procedure, two patients had tran-
sient arrhythmia; one had atrial tachycardia and
one had complete atrioventricular block. In both
cases, the arrhythmia subsided spontaneously.
There were no other complications in the study.
Twenty (25.6%) patients had small residual in-
teratrial shunt on the next day. Only five patients
still had persistent small residual shunt during
follow-up (6.4%). The mean duration of follow-
up was 21.6 ± 12.0 months (range, 1–46 months).
There were no statistically significant differences
between groups A and B with regard to the pro-
cedure failure rate (p = 0.682), complications (p =
1.0) and the presence of residual shunt (p = 0.381)
during follow-up (Table 2).
Discussion
Surgical repair of ASD can be performed success-
fully with low mortality. However, the morbi-
dities associated with cardiopulmonary bypass,
prolonged hospital stay, post-pericardiotomy syn-
drome, and surgical scarring are considerable.12
Since the first attempt in 1974 by King and Mills,13
transcatheter closure of ASD is now becoming 
an acceptable alternative to cardiac surgery. Such
management is safe and may decrease morbidity,
length of hospital stay and cost when compared
to surgical closure.14–17 The ASO has been well
described as an innovative self-centering and self-
expanding device that is repositionable and is 
effective for ASD closure.1–4
The ASO was designed to close ASD with a cen-
tral waist to occupy the defect and two flat disks
to eliminate any residual flow across the septum.6
To achieve stable fixation of the ASO and complete
defect closure, and to avoid damage to the nearby
structures, it is crucial that there are adequate sur-
rounding rims to serve as the support on which
the left and right atrial disks can anchor onto to
form a triple-layer sandwich configuration. Since
the left atrial disk and right atrial disk differ in
radius by 2–3 mm, depending on the diameter of
the waist, thin rim <3mm may not allow sufficient
contact of the ASO disks for device stabilization.
Furthermore, insufficient ASD rims may lead to
compromise of nearby vessels or atrioventricular
valves by the disk after ASO implantation.
The atrial septum is surrounded by several
important structures. The aortic root is located
anterosuperiorly, the mitral valve and tricuspid
valve anteroinferiorly, the superior vena cava and
right upper pulmonary vein posterosuperiorly
and the inferior vena cava posteroinferiorly. SA
rim deficiency is common, with reported inci-
dences ranging from 28% to 54%.6–10 In the
present study, the incidence of SA rim deficiency
was 40.5%.
Although ASD repair by transcatheter ASO
closure is increasingly gaining acceptance,7,8 one
of its problems is that the superior aspect of the
left atrial disk tends to prolapse across the defect
into the right atrium in patients with SA rim de-
ficiency. To overcome this problem, some tech-
niques have been developed, such as using a
large curve delivery sheath or deployment of the
left atrial disk at the orifice regions of the right or
left upper pulmonary vein.18,19 In our study, for
ASD without rim deficiency, the chosen ASO size
was equal to or 1–2 mm larger than the mea-
sured ASD diameter. For ASD with deficient SA
rim, the chosen ASO size was 2–4 mm larger than
the measured ASD diameter. By following this
Table 2. Outcomes of patients with and without superior-anterior (SA) rim deficiency
Group A: deficient SA rim Group B: sufficient SA rim
p
(n = 34) (n = 50)
Failure 3 3 0.682
Complication 1 1 1.000
Persistent residual shunt 3 2 0.381
C.F. Huang, et al
990 J Formos Med Assoc | 2007 • Vol 106 • No 12
strategy, we found that the procedure failure rate,
complications and residual shunt were not statis-
tically significantly different between groups A
and B during the follow-up period.
There were six patients in this study in whom
the procedure failed; two were children and four
were adults. In the two pediatric patients (age, 4.7
and 10.1 years; body weight, 18.9 and 31.8 kg),
ASD diameter was 24 mm and 26 mm. In both,
the ASD was considered large for their age. The rea-
son for failure was due to small left atrial capacity
in which the left atrial disc was unable to expand
fully. In the light of these two cases, under such
circumstances, the ASO was deployed via the pul-
monary veins and such large defects in pediatric
patients could be successfully closed. In the four
adult patients in whom the procedure failed, the
reasons for failure were: large ASD and ASO 
prolapsed into the right atrium in one; very thin
interatrial septum that was torn by the ASO while
the left atrial disc was pulled from the left atrium
into the right atrium, increasing the diameter
from 25 mm to 39 mm in one (Figure 3); occlud-
ers migrated to the right ventricle in two—one
immediately and one on the following day. In
the former, the ASD size measured by TEE was
36 mm and the patient had vigorous cough that
led to ASO dislodgment immediately after recovery
from general anesthesia. Therefore, prevention of
severe cough during recovery from general anesthe-
sia is recommended.20 In the latter, the ASD size
measured during the operation was 45 × 25 mm,
which was larger than that measured by TEE
(34 mm) in the catheterization room, and thus
ASO dislodgment was due to the underestimation
of ASD size.
The reported complication rate of ASD closure
by ASO is relatively low (6.4–7.2%) compared
with surgery (24–68.2%).14,21 Atrial tachyarrhyth-
mia, complete atrioventricular block, thromboem-
bolism, transient ischemic attack, intravascular
hemolysis, atrioventricular valve damage, device
migration, perforation of a nearby structure, and
even mortality have been reported.2,14,18,21–24 In
our study, only two patients (2.4%) had tran-
sient arrhythmia during the procedure, and both
had spontaneous recovery. There were no other
complications in the study.
Trivial residual leaks are not uncommon after
ASO implantation, but usually diminish during
follow-up.7 In our series, immediate residual shunt
was found in 20 patients (25.6%). During follow-
up (range, 1–46 months), persistent small residual
shunt was found in five patients (6.4%). Since
these patients were asymptomatic, no further treat-
ment was undertaken. Occasionally, the ASO disk
may impinge on the aorta and induce perfora-
tion, probably due to application of over-sized
ASO.25 In our study, the ASO size was equal to or
not more than 4 mm larger than the measured
ASD diameter. There was no vascular impingement
in our cases.
A B
Figure 3. (A) Atrial septal defect with thin interatrial septum (arrow). (B) Atrial septal defect diameter increased to
39 mm (arrowheads) after failed Amplatzer septal occluder implantation. LA = left atrium; RA = right atrium.
ASD with deficient SA rim is a common vari-
ation. Similar to ASD with sufficient rims, trans-
catheter closure of secundum type ASD is also
effective for ASD with SA rim deficiency.
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